All Whitepapers Posts

Achieving significant and lasting cost savings by changing the way retailers approach the persistent problems of shrink and concealed losses. For an industry where company margins typically hover between 1% and 2%, shrink remains a critical opportunity to enhance company performance and improve the bottom line. While most retailers have tried a variety of tactics to reduce shrink’s monthly toll on profitability, for many it remains READ MORE>>

Background As Pharmaceutical companies shift their emphasis away from the blockbuster model, they need to bring a broader portfolio of drugs to market. This escalates the complexity of clinical trials—the most costly and time-consuming component of the drug R&D cycle—through higher costs, recruitment challenges and new training demands. A potentially more serious problem is discussed less frequently, however: the increased risk to regulatory compliance and patient READ MORE>>